CodeLab Capital AS (OSL: CODE)
Norway
· Delayed Price · Currency is NOK 0.0644
+0.0052 (8.78%)
Nov 21, 2024, 4:25 PM CET
CodeLab Capital AS Revenue
CodeLab Capital AS had revenue of 30.52K NOK in the quarter ending June 30, 2024, a decrease of -99.69%. This brings the company's revenue in the last twelve months to 2.88M, down -98.12% year-over-year. In the year 2023, CodeLab Capital AS had annual revenue of 59.17M, down -69.66%.
Revenue (ttm)
2.88M
Revenue Growth
-98.12%
P/S Ratio
n/a
Revenue / Employee
99.47K
Employees
29
Market Cap
22.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 59.17M | -135.83M | -69.66% |
| Dec 31, 2022 | 195.01M | -13.63M | -6.53% |
| Dec 31, 2021 | 208.63M | 68.85M | 49.26% |
| Dec 31, 2020 | 139.78M | 24.97M | 21.75% |
| Dec 31, 2019 | 114.80M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nordhealth AS | 513.81M |
| Medistim ASA | 541.82M |
| Photocure ASA | 526.25M |
| Carasent ASA | 264.80M |
| Nykode Therapeutics AS | 69.44M |
| ArcticZymes Technologies ASA | 110.76M |
| Gentian Diagnostics ASA | 154.12M |
| Hofseth BioCare ASA | 248.08M |